Colesevelam hydrochloride (Cholestagel): A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects Academic Article Article uri icon

Overview

MeSH Major

  • Desensitization, Immunologic
  • HLA Antigens
  • Hematopoietic Stem Cell Transplantation
  • Leukemia, Myeloid, Acute

abstract

  • Colesevelam therapy is effective for lowering low-density lipoprotein cholesterol concentrations in persons with moderate hypercholesterolemia. It lacks the constipating effect of other bile acid sequestrants, demonstrating the potential for increased compliance.

publication date

  • September 13, 1999

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1001/archinte.159.16.1893

PubMed ID

  • 10493319

Additional Document Info

start page

  • 1893

end page

  • 900

volume

  • 159

number

  • 16